Hayward, CA, United States of America

Catherine Middleton-Hardie

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Acologix, Inc., Orthotrophix, Inc.. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Middleton-Hardie. Retrieved from https://idiyas.com/inventor/catherine-middleton-hardie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0



Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Catherine Middleton-Hardie

Introduction

Catherine Middleton-Hardie is an accomplished inventor based in Hayward, California, renowned for her contributions to the field of biotechnology. With a keen focus on tissue engineering, she has been instrumental in developing innovative solutions that address critical health challenges. Over the span of her career, Catherine has accumulated a total of four patents, underscoring her dedication to advancing medical science.

Latest Patents

Among her most notable contributions is a patent concerning a peptide composition and a method of promoting cartilage formation. This groundbreaking invention includes a peptide compound that stimulates the formation of hard tissues such as bone and cartilage. The patent is particularly significant in providing a method to treat defects in hard tissues caused by conditions like rheumatoid arthritis or osteoarthritis. The methodology focuses on regenerating new bone or cartilage in and around these defects, thus paving the way for improved therapies in regenerative medicine.

Career Highlights

Catherine has had a rich career, contributing her expertise to esteemed organizations such as Acologix, Inc. and Orthotrophix, Inc. Her work in these companies has allowed her to innovate and collaborate on projects that make a tangible impact on patient care and treatment outcomes. Her commitment to research and development has not only led to her personal achievements but has also significantly advanced the field of regenerative medicine.

Collaborations

Throughout her career, Catherine has collaborated with several talented individuals, including Mirella Lazarov and David Rosen. These partnerships have enhanced the scope of her innovations, bringing together diverse skills and insights to address complex medical issues effectively. Working alongside such esteemed colleagues has facilitated a fruitful exchange of ideas, leading to further advancements in her research.

Conclusion

Catherine Middleton-Hardie's work exemplifies the spirit of innovation and dedication present in the field of biotechnology. With her focus on the regeneration of hard tissues and her notable patents, she continues to contribute to significant advancements in healthcare. As her career progresses, the impact of her inventions is sure to resonate throughout the medical community and improve the lives of many individuals facing health challenges related to bone and cartilage defects.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…